Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Cardiac Imaging in Systemic Disorders: the ORACLES Registry
Clinical trial registry update for the ORACLES Registry, examining cardiac imaging in systemic lupus erythematosus; the study status is NOT_…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants.. [Phase 1]
Phase 1 trial evaluating ACT100 in healthy participants to characterize safety, tolerability, and PK/PD. The study is sponsored by Xiamen Am…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus [Phase 3]
A Phase 3 clinical trial of MIL62 for systemic lupus erythematosus is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases [EARLY_Phase 1]
An early-phase (Phase 1) clinical trial evaluating QT-019C UCAR T-cell therapy targeting CD19/BCMA for relapse or refractory autoimmune dise…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Study of CD19 CAR-T Therapy for Refractory SLE [Phase 1]
A Phase 1 clinical trial is evaluating a CD19 CAR-T cell therapy for refractory systemic lupus erythematosus, with recruitment ongoing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus [Phase 3]
This document provides an update on a Phase 3 clinical trial evaluating the safety of litifilimab injections and whether they can improve sy…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: " TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus
A clinical trial led by South Valley University is investigating TREX1 gene mutations and their role in systemic lupus erythematosus. Recrui…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: The Effect of Clinical Pilates Training on Fatigue, Emotional State, Functional Capacity, Sleep and Quality of Life in Women With Systemic Lupus Erythematosus [NA]
A clinical trial studying whether clinical Pilates training affects fatigue, emotional state, functional capacity, sleep, and quality of lif…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry
CorEvitas is conducting a systemic lupus erythematosus drug safety and effectiveness registry. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Omega-3 Supplementation in Systemic Lupus Erythematosus [NA]
This clinical trial update notes a study in systemic lupus erythematosus evaluating omega-3 supplementation, sponsored by the University of …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating YK012 for moderate to severe Systemic Lupus Erythematosus is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus [Phase 1]
Phase 1 clinical trial evaluating anti-CD19 CAR-T cell therapy for refractory systemic lupus erythematosus.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Multi-component, Person-centered, and Yoga-based Coaching Program for Lupus Chronic Pain [NA]
A clinical trial assessing a multi-component, person-centered, and yoga-based coaching program aimed at reducing pain in people with systemi…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease [Phase 1]
Phase 1 clinical trial update for a CAR T-cell therapy targeting CD19 and BCMA in autoimmune conditions, with recruiting status and potentia…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases [NA]
This entry describes an ongoing clinical trial at University Hospital, Bordeaux evaluating whether immune mediators and metabolites can stra…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
Early-phase clinical study of a targeted CD19/BCMA CAR-T therapy for autoimmune diseases is recruiting, including systemic lupus erythematos…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.
A prospective comparative study will evaluate the efficacy and safety of Telitacicept and Belimumab in systemic lupus erythematosus. The stu…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus [Phase 4]
A Phase 4 clinical trial is investigating the efficacy and safety of IL-1 inhibitors for mild to moderate systemic lupus erythematosus and i…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM) [Phase 1]
A Phase 1 trial update indicates Nanjing Legend Biotech is recruiting for LUCAR-G79D to treat relapsed/refractory systemic lupus erythematos…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: The Burden of Lupus in Canada From a Patient Perspective: A Canadian Real-World PROxy Study
A completed Canadian real-world study evaluating the burden of lupus from the patient perspective using patient-reported outcomes. It focuse…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy [EARLY_Phase 1]
An early-phase 1 clinical trial of IMPT-514 in systemic lupus erythematosus, ANCA-associated vasculitis, and idiopathic inflammatory myopath…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE [Phase 1]
Phase 1 trial update evaluating safety, tolerability, pharmacokinetics, immunogenicity and preliminary efficacy of HC022 injection in system…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease [Phase 4]
Phase 4 clinical trial comparing telitacicept to cyclophosphamide for lupus-related interstitial lung disease, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis [Phase 1]
Phase 1 study evaluating UB-VV410 in adults with active refractory systemic lupus erythematosus or lupus nephritis; recruitment is currently…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Research Accelerated by You Lupus Registry
This clinical trial registry entry describes the Lupus Registry study sponsored by the Lupus Foundation of America, which is currently recru…